The present invention provides anti-inflammatory compounds, pharmaceutical
compositions thereof, and methods of use thereof for treating
inflammatory disorders. The present invention also provides methods of
identifying anti-inflammatory compounds and methods of inhibiting
NF-.kappa.B-dependent target gene expression in a cell.